Highmark Health launches diabetes management program with Onduo by Verily
Highmark Health is launching Well360 Diabetes Management, a virtual care program powered by Onduo, a Verily company, for adults with type 2 diabetes. As part of Highmark Health's Living Health model, the program is designed to give members simple, personalized, and proactive support to better manage the chronic condition, improve health outcomes, and reduce costs.
Personalized virtual care for better health
Innovative, multi-condition, whole person care.
-
The end of one-size-fits-all
At Onduo by Verily, we use the science of “digital phenotyping” to identify peoples' needs, characteristics, and drivers. We combine that with real-time data from sensing devices, pharmacy records, app activity, and more*, and recommend best next steps to deliver truly personalized care, flagging high-risk individuals for a telemedicine visit, tackling medication adherence issues, or assigning activities to relieve stress.
-
Digital connected care. Built on next-generation technology.
We make healthy “easy” with our customized approach to chronic condition management. Our virtual care model, centered around the Onduo app, offers individual learning paths; health coaching based on goals; novel sensing devices; food and exercise tracking; in-app telemedicine visits; medication optimizations; and more.
-
Life-changing results
Onduo incorporates novel sensing and connected devices to help members understand their health and make changes that deliver results. Participants in our weight loss program who lost weight saw an average loss of 17 pounds or 8% of their total weight1. And in our published study of people with type 2 diabetes using continuous glucose monitoring (CGM) systems, Onduo members experienced better blood glucose control (2.4 hours increased time in range per day) while lowering their blood pressure and cholesterol2.
-
Verily technology + the Onduo care team
What do you get by combining them? To start: advanced predictive analytics, expert behavioral science, and true personalization at scale. Our data-driven insights enable us to match the right care, to the right person, at the right time. As a result, our coaches, nutritionists, pharmacists, and doctors can step in when it’s most meaningful; lowering risks and reducing costs.
-
Personalization
-
Our Model
-
Novel Sensing Devices
-
View Our Clinic
Now available for more conditions
The Onduo program provides both clinical and lifestyle interventions and deepen member engagement.
Type 1* & 2 diabetes
Members receive a blood glucose monitor, unlimited test strips, and support from care leads and diabetes educators.
*Available Q3 2022
High blood pressure
Members receive a blood pressure cuff, digital and connected coaching, medication adherence counseling, and access to telemedicine via the Onduo app. We work to reach a controlled blood pressure target by building healthy habits and behaviors to help reduce the risk of future health problems.
Weight loss and diabetes prevention
Onduo offers a CDC-recognized Diabetes Prevention Program through Good Measures providing one-on-one and group support to help individuals work on nutrition, physical activity, and weight loss. Onduo Healthy Weight is tailored to help individuals achieve and maintain their goals. Members receive a connected scale, personalized coaching, and app featuring the patented Good Measures Index.
Mental and behavioral health
Through providing digital tools, evidence-based interventions, resources, and reflection exercises, we help employees and members understand the impact of their symptoms on their daily living.
*Through its contracted relationships and member-level user agreements, Onduo is able to access individual-level data.
1Data on file, Sept 2021. No individual result should be seen as typical; they are not guaranteed results. Individual weight loss results, amount, and time duration will vary.
2Majithia A et al. Glycemic Outcomes in Adults With Type 2 Diabetes Participating in a Continuous Glucose Monitor–Driven Virtual Diabetes Clinic: Prospective Trial. J Med Internet Res. 2020: 22(8):e21778.
